Report Content
Chapter 1 Methodology & Scope
1.1 Market definations
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Over the counter (OTC) drugs market industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Distribution channel trends
2.1.4 Regional trends
Chapter 3 Over the Counter (OTC) Drugs Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Pharmaceutical companies switching from Rx to OTC drugs especially in the U.S
3.3.1.2 Growing trend of self-medication in developing economies
3.3.1.3 Significant cost savings due to OTC drug usage in Asia Pacific and Latin America
3.3.2 Industry pitfalls & challenges
3.3.2.1 Several concerns pertaining to incorrect diagnosis and substance abuse
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By distribution channel
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of new entrants
3.7.4 Threat of substitutes
3.7.5 Industry rivalry
3.8 PESTLE analysis
3.8.1 Political
3.8.2 Economical
3.8.3 Social
3.8.4 Technological
3.8.5 Legal
3.8.6 Environmental
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 Company 1
4.1.2 Company 2
4.1.3 Company 3
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Over the Counter (OTC) Drugs Market, By Product
5.1 Key segment trends
5.2 Analgesics
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Cold, cough & flu products
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Weight loss products
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Gastrointestinal products
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Skin products
5.6.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Minerals and vitamin supplements
5.7.1 Market size, by region, 2018 - 2032 (USD Million)
5.8 Sleeping aids
5.8.1 Market size, by region, 2018 - 2032 (USD Million)
5.9 Ophthalmic products
5.9.1 Market size, by region, 2018 - 2032 (USD Million)
5.10 Others
5.10.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Over the Counter (OTC) Drugs Market, By Distribution Channel
6.1 Key segment trends
6.2 Hospital pharmacy
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Retail pharmacy
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Online medstores
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Over the Counter (OTC) Drugs Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2018 - 2032 (USD Million)
7.2.2 Market size, by product, 2018 - 2032 (USD Million)
7.2.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.2.4 U.S.
7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.2.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.2.5 Canada
7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.2.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.2 Market size, by product, 2018 - 2032 (USD Million)
7.3.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.4 Germany
7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.5 UK
7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.6 France
7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.7 Italy
7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.7.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.8 Spain
7.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.8.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.9 Russia
7.3.9.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.9.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.3.10 Poland
7.3.10.1 Market size, by product, 2018 - 2032 (USD Million)
7.3.10.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.2 Market size, by product, 2018 - 2032 (USD Million)
7.4.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4.4 China
7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4.6 India
7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4.7 Australia
7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.7.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4.8 South Korea
7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.8.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.4.9 Taiwan
7.4.9.1 Market size, by product, 2018 - 2032 (USD Million)
7.4.9.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.5.2 Market size, by product, 2018 - 2032 (USD Million)
7.5.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.5.4 Brazil
7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.5.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.5.5 Mexico
7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.5.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.5.6 Argentina
7.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
7.5.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.6 Middle East & Africa
7.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.6.2 Market size, by product, 2018 - 2032 (USD Million)
7.6.3 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.6.4 South Africa
7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
7.6.4.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.6.5 Saudi Arabia
7.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
7.6.5.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.6.6 Qatar
7.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
7.6.6.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.6.7 Nigeria
7.6.7.1 Market size, by product, 2018 - 2032 (USD Million)
7.6.7.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
7.6.8 Kuwait
7.6.8.1 Market size, by product, 2018 - 2032 (USD Million)
7.6.8.2 Market size, by distribution channel, 2018 - 2032 (USD Million)
Chapter 8 Company Profiles
8.1 Bayer AG.
8.1.1 Business overview
8.1.2 Financial data
8.1.3 Product landscape
8.1.4 Strategic outlook
8.1.5 SWOT analysis
8.2 GlaxoSmithKline (GSK).
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Sanofi
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Johnson & Johnson
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Sun Pharmaceutical Industries Ltd
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Alkem Laboratories Limited
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Cipla, Inc
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Reckitt Benckiser Group Plc.
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Piramal Enterprises Limited
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Teva Pharmaceutical Industries Ltd
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Glenmark Pharmaceuticals Ltd
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 The Blackstone Group, Inc. (Alinamin Pharmaceutical Co., Ltd.)
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Aytu Biopharma, Inc. (Aytu Consumer Health, Inc.)
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Dr. Reddy's Laboratories
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
8.15 Viatris, Inc. (Mylan, Inc.)
8.15.1 Business overview
8.15.2 Financial data
8.15.3 Product landscape
8.15.4 Strategic outlook
8.15.5 SWOT analysis
